ArticleMolecular cancer therapeutics2013

Cyclin d1 downregulation contributes to anticancer effect of isorhapontigenin on human bladder cancer cells.

Yong Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.